NO904822L - Fremgangsmaate for fremstilling av pyridinderivater. - Google Patents

Fremgangsmaate for fremstilling av pyridinderivater.

Info

Publication number
NO904822L
NO904822L NO90904822A NO904822A NO904822L NO 904822 L NO904822 L NO 904822L NO 90904822 A NO90904822 A NO 90904822A NO 904822 A NO904822 A NO 904822A NO 904822 L NO904822 L NO 904822L
Authority
NO
Norway
Prior art keywords
procedure
pyridine derivatives
preparing pyridine
preparing
derivatives
Prior art date
Application number
NO90904822A
Other languages
English (en)
Other versions
NO177263B (no
NO904822D0 (no
NO177263C (no
Inventor
Gyoergy Domany
Elemer Ezer
Istvan Schon
Judit Matuz
Katalin Saghy
Laszlo Szporny
Gyoergy Hajos
Marta Renyei
Original Assignee
Richter Gedeon Vegyeszeti Gyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyer filed Critical Richter Gedeon Vegyeszeti Gyer
Publication of NO904822D0 publication Critical patent/NO904822D0/no
Publication of NO904822L publication Critical patent/NO904822L/no
Publication of NO177263B publication Critical patent/NO177263B/no
Publication of NO177263C publication Critical patent/NO177263C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
NO904822A 1989-11-07 1990-11-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater NO177263C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895807A HU207047B (en) 1989-11-07 1989-11-07 Process for producing new pyridine derivatives and pharmaceutical copositions comprising same

Publications (4)

Publication Number Publication Date
NO904822D0 NO904822D0 (no) 1990-11-06
NO904822L true NO904822L (no) 1991-05-08
NO177263B NO177263B (no) 1995-05-08
NO177263C NO177263C (no) 1995-08-16

Family

ID=10970765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904822A NO177263C (no) 1989-11-07 1990-11-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater

Country Status (20)

Country Link
US (1) US5155123A (no)
EP (1) EP0427526B1 (no)
JP (1) JPH03169862A (no)
KR (1) KR910009663A (no)
CN (1) CN1052305A (no)
AR (1) AR248394A1 (no)
AT (1) ATE109137T1 (no)
AU (1) AU631261B2 (no)
CA (1) CA2029222A1 (no)
DE (1) DE69011046T2 (no)
DK (1) DK0427526T3 (no)
ES (1) ES2057441T3 (no)
FI (1) FI905493A0 (no)
HU (1) HU207047B (no)
IL (1) IL96252A (no)
IN (1) IN171700B (no)
NO (1) NO177263C (no)
NZ (1) NZ235984A (no)
PH (1) PH27440A (no)
ZA (1) ZA908889B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1394150T3 (da) 1999-02-24 2011-03-21 Hoffmann La Roche 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
TWI280239B (en) 2003-07-15 2007-05-01 Hoffmann La Roche Process for preparation of pyridine derivatives
DK1928427T3 (da) 2005-09-23 2010-03-08 Hoffmann La Roche Hidtil ukendt dosisformulering
CU24170B1 (es) * 2010-08-31 2016-03-31 Meiji Seika Pharma Co Derivados de amina y sus sales para el control de plagas
BR112014004268A8 (pt) * 2011-08-26 2023-01-17 Meiji Seika Pharma Co Ltd método para a produção de agente de controle de praga
CN112585137A (zh) 2018-08-07 2021-03-30 先正达农作物保护股份公司 杀有害生物活性的二环杂芳香族化合物
AR117291A1 (es) 2018-12-14 2021-07-28 Syngenta Crop Protection Ag Compuestos heterocíclicos de cianamida con actividad pesticida
WO2020169526A1 (en) 2019-02-18 2020-08-27 Syngenta Crop Protection Ag Pesticidally-active cyanamide heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201119A (en) * 1978-09-18 1986-02-25 Mcneilab, Inc. Diaza-cyclic derivatives of guanidine
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
JPH07121909B2 (ja) * 1986-09-10 1995-12-25 日本バイエルアグロケム株式会社 新規複素環式化合物及び殺虫剤

Also Published As

Publication number Publication date
AU631261B2 (en) 1992-11-19
NO177263B (no) 1995-05-08
JPH03169862A (ja) 1991-07-23
EP0427526A1 (en) 1991-05-15
DK0427526T3 (da) 1994-08-29
DE69011046D1 (de) 1994-09-01
EP0427526B1 (en) 1994-07-27
CN1052305A (zh) 1991-06-19
KR910009663A (ko) 1991-06-28
IL96252A (en) 1994-12-29
ATE109137T1 (de) 1994-08-15
US5155123A (en) 1992-10-13
HUT55758A (en) 1991-06-28
ZA908889B (en) 1991-10-30
PH27440A (en) 1993-07-02
ES2057441T3 (es) 1994-10-16
IN171700B (no) 1992-12-12
NO904822D0 (no) 1990-11-06
AU6582390A (en) 1991-05-23
HU895807D0 (en) 1990-01-28
AR248394A1 (es) 1995-08-18
FI905493A0 (fi) 1990-11-06
NZ235984A (en) 1992-08-26
NO177263C (no) 1995-08-16
HU207047B (en) 1993-03-01
IL96252A0 (en) 1991-08-16
DE69011046T2 (de) 1994-11-24
CA2029222A1 (en) 1991-05-08

Similar Documents

Publication Publication Date Title
NO903656L (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
NO904987D0 (no) Fremgangsmaate for fremstilling av indolderivater.
NO164242C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903780L (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO904822L (no) Fremgangsmaate for fremstilling av pyridinderivater.
NO882528L (no) Fremgangsmaate ved fremstilling av 2-metoksymetyl-penem-derivater.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO885435D0 (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO893713D0 (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO880992D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
NO883398L (no) Fremgangsmaate for fremstilling av benzoksazin-derivater.
NO903196L (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.